An up­start im­munother­a­py biotech emerges from stealth mode with big love for Kendall Square

When Ron Sei­del and Rodol­fo “Rudy” Chap­ar­ro had to sit down and de­cide where to base their new biotech, the two in­ves­ti­ga­tors at Al­bert Ein­stein Col­lege of Med­i­cine in New York could have gone just about any­where in the US that they want­ed. Stay­ing in New York would have worked. One had fam­i­ly in Cal­i­for­nia to con­sid­er. But a year ago, they chose Cam­bridge, MA, and start­ed build­ing their team in a place on Kendall Square.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.